Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Natural history of nasal vestibulitis associated with paclitaxel, docetaxel, and other chemotherapy agents: a Minnesota Cancer Clinical Trials Network (MNCCTN) study.
Cathcart-Rake EJ, Zahrieh D, Smith D, Young S, McCue S, O'Connor A, Thomé S, Lacouture M, Register T, Piens J, Friday BB, Loprinzi CL. Cathcart-Rake EJ, et al. Among authors: friday bb. Support Care Cancer. 2021 Nov;29(11):6253-6258. doi: 10.1007/s00520-021-06190-0. Epub 2021 Apr 13. Support Care Cancer. 2021. PMID: 33851235
A five arm natural history study of nasal vestibulitis.
Cathcart-Rake EJ, Zahrieh D, Smith D, Young S, McCue S, O'Connor A, Thomé S, Lacouture M, Register T, Piens J, Friday BB, Loprinzi CL. Cathcart-Rake EJ, et al. Among authors: friday bb. Cancer Med. 2023 Apr;12(8):9650-9654. doi: 10.1002/cam4.5887. Epub 2023 Apr 5. Cancer Med. 2023. PMID: 37017603 Free PMC article.
Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial.
Sarkaria JN, Ballman KV, Kizilbash SH, Sulman EP, Giannini C, Friday BB, Butowski NA, Mohile NA, Piccioni DE, Battiste JD, Drappatz J, Campian JL, Mashru S, Jaeckle KA, O'Brien BJ, Dixon JG, Kabat BF, Laack NL, Hu LS, Kaufmann T, Kumthekar P, Ellingson BM, Anderson SK, Galanis E. Sarkaria JN, et al. Among authors: friday bb. JAMA Oncol. 2024 Oct 31:e244361. doi: 10.1001/jamaoncol.2024.4361. Online ahead of print. JAMA Oncol. 2024. PMID: 39480453
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial.
Saad F, Fizazi K, Jinga V, Efstathiou E, Fong PC, Hart LL, Jones R, McDermott R, Wirth M, Suzuki K, MacLean DB, Wang L, Akaza H, Nelson J, Scher HI, Dreicer R, Webb IJ, de Wit R; ELM-PC 4 investigators. Saad F, et al. Lancet Oncol. 2015 Mar;16(3):338-48. doi: 10.1016/S1470-2045(15)70027-6. Epub 2015 Feb 18. Lancet Oncol. 2015. PMID: 25701170 Clinical Trial.
23 results